TY  - GEN
AU  - Tighe,Donal
AU  - McNamara,Deirdre
TI  - Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
SN  - 2219-2840
PY  - 2017///0717
KW  - Adalimumab
KW  - administration & dosage
KW  - Anti-Inflammatory Agents
KW  - Azathioprine
KW  - Drug Resistance
KW  - immunology
KW  - Drug Therapy, Combination
KW  - Gastrointestinal Agents
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Inflammatory Bowel Diseases
KW  - drug therapy
KW  - Infliximab
KW  - Monitoring, Immunologic
KW  - Quality of Life
KW  - Remission Induction
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
KW  - Withholding Treatment
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.3748/wjg.v23.i3.414
ER  -